Home GSK US
The homepage of the GSK USA website. Press releases. 29 March 2021 Lilly, Vir Biotechnology and GSK announce positive topline data from the phase 2 BLAZE-4 trial evaluating bamlanivimab with VIR-7831 in low-risk adults with COVID-19 ; 26 March 2021 GSK and Vir Biotechnology announce submission of Emergency Use Authorization request to FDA for VIR-7831 for the early treatment of COVID-19
Actived: Just Now
Home Page [contactus.gsk.com]
Samples and Savings Offers: We appreciate your interest in the GSK Healthcare Professional portal, GSKPro.com.This website service is intended for US Healthcare Professionals only. The site contains the latest information on therapy areas and GSK products, along with a …
General Privacy Notice
To turn off personalisation for advertisements served by Google click here. To turn off personalisation for advertisements served by Facebook click here . Many companies that display interest-based advertising are members of the Network Advertising Initiative ("NAI"), the Digital Advertising Alliance ("DAA") or the European Interactive Digital
FDA approves GSK’s Voltaren Arthritis Pain for over-the
Warren, New Jersey, USA. GlaxoSmithKline (LSE/NYSE: GSK) today announced that the U.S. Food and Drug Administration (FDA) has approved Voltaren Arthritis Pain (diclofenac sodium topical gel, 1% (NSAID)- arthritis pain reliever) as an over-the-counter (OTC) product for the temporary relief of arthritis pain in the hand, wrist, elbow, foot, ankle or knee in adults (18 years and older).
Lamisil GSK Australia
Lamisil Lamisil offers a range of antifungal products used to treat athlete’s foot, ringworm or jock itch. Lamisil Cream, Lamisil Spray and Lamisil Derm Gel, for the treatment of fungal infections of the skin such as athlete’s foot, jock itch and ringworm.